FR7131M - - Google Patents

Info

Publication number
FR7131M
FR7131M FR138081A FR138081A FR7131M FR 7131 M FR7131 M FR 7131M FR 138081 A FR138081 A FR 138081A FR 138081 A FR138081 A FR 138081A FR 7131 M FR7131 M FR 7131M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR138081A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR138081A priority Critical patent/FR7131M/fr
Priority to BE726760D priority patent/BE726760A/xx
Priority to DE19691902227 priority patent/DE1902227A1/de
Priority to CA41495A priority patent/CA939266A/en
Priority to GB1256914D priority patent/GB1256914A/en
Application granted granted Critical
Publication of FR7131M publication Critical patent/FR7131M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR138081A 1968-01-31 1968-01-31 Expired FR7131M (xx)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR138081A FR7131M (xx) 1968-01-31 1968-01-31
BE726760D BE726760A (xx) 1968-01-31 1969-01-10
DE19691902227 DE1902227A1 (de) 1968-01-31 1969-01-17 Arzneimittel zur psychotherapeutischen Anwendung und Verfahren zu seiner Herstellung
CA41495A CA939266A (en) 1968-01-31 1969-01-29 Medicament agissant au niveau du systeme nerveux central utilisable dans les traitements psychoterapiques et comme anti-drogue
GB1256914D GB1256914A (xx) 1968-01-31 1969-01-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR138081A FR7131M (xx) 1968-01-31 1968-01-31

Publications (1)

Publication Number Publication Date
FR7131M true FR7131M (xx) 1969-07-21

Family

ID=8645336

Family Applications (1)

Application Number Title Priority Date Filing Date
FR138081A Expired FR7131M (xx) 1968-01-31 1968-01-31

Country Status (5)

Country Link
BE (1) BE726760A (xx)
CA (1) CA939266A (xx)
DE (1) DE1902227A1 (xx)
FR (1) FR7131M (xx)
GB (1) GB1256914A (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214034A (en) * 1986-09-26 1993-05-25 Mitsui Toatsu Chemicals, Incorporated Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same
FI874163A (fi) * 1986-09-26 1988-03-27 Mitsui Toatsu Chemicals Katekolderivat samt preparat innehaollande desamma foer haemmande och botande av regressiva sjukdomar i det centrala nervsystemet.
US4857523A (en) * 1988-07-18 1989-08-15 Nda International, Inc. Rapid method for attenuating the alcohol dependency syndrome
US5290793A (en) * 1989-09-12 1994-03-01 Mitsui Toatsu Chemicals, Incorporated Dihydrocaffeic acid derivatives and pharmaceutical preparation containing same
US5152994A (en) * 1990-05-31 1992-10-06 Lotsof Howard S Rapid method for interrupting or attenuating poly-drug dependency syndromes
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
ES2224430T3 (es) 1997-09-04 2005-03-01 Novoneuron Inc Noribogaina en el tratamiento del dolor y de la toxicomania.
ATE519485T1 (de) * 2001-03-29 2011-08-15 Michael Davis Akute pharmakologische verstärkung einer psychotherapie mit d-cycloserine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
JP6049615B2 (ja) 2010-07-23 2016-12-21 デマークス・インコーポレイテッドＤｅｍｅｒｘ，Ｉｎｃ． ノリボガイン組成物
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
WO2013085922A1 (en) 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
US8877921B2 (en) 2012-01-25 2014-11-04 Demerx, Inc. Synthetic voacangine
JP2016508979A (ja) 2012-12-20 2016-03-24 デメレックス， インコーポレイテッド 置換ノルイボガイン
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
US9561233B2 (en) 2014-03-13 2017-02-07 Demerx, Inc. Use of ibogaine for the treatment of pain
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9592239B2 (en) 2014-09-12 2017-03-14 Demerx, Inc. Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake

Also Published As

Publication number Publication date
DE1902227A1 (de) 1969-09-04
GB1256914A (xx) 1971-12-15
CA939266A (en) 1974-01-01
BE726760A (xx) 1969-06-16

Similar Documents

Publication Publication Date Title
FR7131M (xx)
AU5506869A (xx)
AU5184069A (xx)
AU6168869A (xx)
AU6171569A (xx)
AU429879B2 (xx)
AU4304568A (xx)
AU4811568A (xx)
AR203075Q (xx)
AU4744468A (xx)
BE725539A (xx)
BE708951A (xx)
BE726444A (xx)
BE725201A (xx)
BE717170A (xx)
BE710420A (xx)
BE709496A (xx)
BE709484A (xx)
BE709479A (xx)
BE709446A (xx)
BE709435A (xx)
BE709415A (xx)
BE709320A (xx)
BE709319A (xx)
BE709301A (xx)

Legal Events

Date Code Title Description
ST Notification of lapse